ES496780A0 - Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b. - Google Patents

Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b.

Info

Publication number
ES496780A0
ES496780A0 ES496780A ES496780A ES496780A0 ES 496780 A0 ES496780 A0 ES 496780A0 ES 496780 A ES496780 A ES 496780A ES 496780 A ES496780 A ES 496780A ES 496780 A0 ES496780 A0 ES 496780A0
Authority
ES
Spain
Prior art keywords
hepatitis
virus
procedure
vitro cell
cell cultivation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES496780A
Other languages
English (en)
Other versions
ES8200398A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES496780A0 publication Critical patent/ES496780A0/es
Publication of ES8200398A1 publication Critical patent/ES8200398A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES496780A 1979-11-13 1980-11-12 Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b. Expired ES8200398A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9365879A 1979-11-13 1979-11-13

Publications (2)

Publication Number Publication Date
ES496780A0 true ES496780A0 (es) 1981-11-01
ES8200398A1 ES8200398A1 (es) 1981-11-01

Family

ID=22240085

Family Applications (1)

Application Number Title Priority Date Filing Date
ES496780A Expired ES8200398A1 (es) 1979-11-13 1980-11-12 Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b.

Country Status (9)

Country Link
EP (1) EP0028987B1 (es)
JP (1) JPS5682089A (es)
AT (1) ATE8108T1 (es)
DE (1) DE3068373D1 (es)
DK (1) DK481480A (es)
ES (1) ES8200398A1 (es)
GR (1) GR71857B (es)
IE (1) IE50339B1 (es)
PT (1) PT72015B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393133A (en) * 1980-06-12 1983-07-12 The Wistar Institute Of Anatomy And Biology Human hepatoma derived cell line, process for preparation thereof, and uses therefor
US4416986A (en) * 1981-01-16 1983-11-22 Merck & Co., Inc. Methods of producing HBsAg
AU702370B2 (en) * 1996-01-29 1999-02-18 Kye-Hyung Paik Method of protein production using mitochondrial translation system
GB9815939D0 (en) * 1998-07-23 1998-09-23 Univ Leicester Hepatitis B culture system
US6562562B2 (en) * 2000-03-10 2003-05-13 Pharmacia & Upjohn S.P.A. Procedure for partial liver resection in nonhuman primates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS48103722A (es) * 1972-04-15 1973-12-26
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro

Also Published As

Publication number Publication date
EP0028987B1 (en) 1984-06-27
DK481480A (da) 1981-05-14
IE802329L (en) 1981-05-13
JPH042231B2 (es) 1992-01-16
EP0028987A3 (en) 1982-05-19
DE3068373D1 (en) 1984-08-02
PT72015B (en) 1982-06-20
JPS5682089A (en) 1981-07-04
ES8200398A1 (es) 1981-11-01
IE50339B1 (en) 1986-04-02
GR71857B (es) 1983-07-05
ATE8108T1 (de) 1984-07-15
PT72015A (en) 1980-12-01
EP0028987A2 (en) 1981-05-20

Similar Documents

Publication Publication Date Title
DK0747485T3 (da) Fremstilling af proteiner ved anvendelse af homolog rekombination
FI930206A (fi) Adoptiv immunoterapi med interleukin-7
ATE7855T1 (de) Herstellung von virusantigenen.
DK372780A (da) Fremgangsmaade til propagering af humant hepatitis a virus
DE69333855D1 (de) Aus einer mit einem Stamm von Multiple-Sklerosis-Virus infizierten Zellinie hergestelltes biologisches Virusmaterial
ES504199A0 (es) Un metodo para aumentar el rendimiento de vha en un cultivo celular in vitro
ATE2442T1 (de) Verfahren zur herstellung von interferon und dabei verwendete kulturmediumzusammensetzung.
ES496780A0 (es) Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b.
ATE10806T1 (de) Verfahren zur herstellung von hepatitis boberfl[chenantigen.
ATE21484T1 (de) An menschliche fibroblastenzellen adaptierte hepatitis-a-viren.
SU549106A1 (ru) Способ сохранени отдаленных гибридов
GB839876A (en) A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus
KR900018379A (ko) 암전이 억제인자의 제조방법
SU1692146A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура o
GB951559A (en) Newcastle disease vaccine and the preparation thereof
GB1355259A (en) Attenuated rubella virus vaccine and production thereof
GB931137A (en) A method of producing canine distemper vaccine
ES407704A1 (es) Procedimiento para la obtencion de proteinas a partir de etanol de sintesis.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303